Global Surrogacy Market Size, Share, Trends, Growth, Report: By Type: Gestational Surrogacy, Traditional Surrogacy; By Technology: IVF with ICSI, IVF without ICSI, Intrauterine Insemination, Others; By End User: Hospitals, IVF Centres, Others; Regional Analysis; Patent Analysis; Grants Analysis; Funding Analysis; Supplier Landscape; 2024-2032

1    Preface
    1.1    Objectives of the Study
    1.2    Key Assumptions 
    1.3    Report Coverage – Key Segmentation and Scope  
    1.4    Research Methodology
2    Executive Summary
3    Global Surrogacy Market (2017-2032) Overview 
    3.1    Global Surrogacy Market Historical Value (2017-2023) 
    3.2    Global Surrogacy Market Forecast Value (2024-2032)
4    Global Surrogacy Market (2017-2032) Landscape*
    4.1    Global Surrogacy Developers Landscape
        4.1.1    Analysis by Year of Establishment
        4.1.2    Analysis by Company Size
        4.1.3    Analysis by Region
    4.2    Global Surrogacy Product Landscape
        4.2.1    Analysis by Type
        4.2.2    Analysis by Technology  
5    Global Surrogacy Market (2017-2032) Dynamics
    5.1    Market Drivers and Constraints
    5.2    SWOT Analysis
        5.2.1    Strengths
        5.2.2    Weaknesses
        5.2.3    Opportunities
        5.2.4    Threats
    5.3    Porter’s Five Forces Model
        5.3.1    Bargaining Power of Suppliers
        5.3.2    Bargaining Power of Buyers
        5.3.3    Threat of New Entrants
        5.3.4    Threat of Substitutes
        5.3.5    Degree of Rivalry
    5.4    Key Demand Indicators 
    5.5    Key Price Indicators
    5.6    Industry Events, Initiatives, and Trends  
    5.7    Value Chain Analysis
6    Global Surrogacy Market (2017-2032) Segmentation 
    6.1    Global Surrogacy Market (2017-2032) by Type
        6.1.1    Market Overview 
        6.1.2    Gestational Surrogacy
        6.1.3    Traditional Surrogacy
    6.2    Global Surrogacy Market (2017-2032) by Technology
        6.2.1    Market Overview
        6.2.2    IVF with ICSI
        6.2.3    IVF without ICSI
        6.2.4    Intrauterine Insemination
        6.2.5    Others
    6.3    Global Surrogacy Market (2017-2032) by End User
        6.3.1    Market Overview
        6.3.2    Hospitals
        6.3.3    IVF Centres
        6.3.4    Others
    6.4    Global Surrogacy Market (2017-2032) by Region
        6.4.1    Market Overview
        6.4.2    North America 
        6.4.3    Europe
        6.4.4    Asia Pacific
        6.4.5    Latin America
        6.4.6    Middle East and Africa
7    North America Surrogacy Market (2017-2032)
    7.1    North America Surrogacy Market (2017-2032) by Type
        7.1.1    Market Overview
        7.1.2    Gestational Surrogacy
        7.1.3    Traditional Surrogacy
    7.2    North America Surrogacy Market (2017-2032) by Technology
        7.2.1    Market Overview
        7.2.2    IVF with ICSI
        7.2.3    IVF without ICSI
        7.2.4    Intrauterine Insemination
        7.2.5    Others
    7.3    North America Surrogacy Market (2017-2032) by Country
        7.3.1    United States of America
        7.3.2    Canada
8    Europe Surrogacy Market (2017-2032)
    8.1    Europe Surrogacy Market (2017-2032) by Type
        8.1.1    Market Overview
        8.1.2    Gestational Surrogacy
        8.1.3    Traditional Surrogacy
    8.2    Europe Surrogacy Market (2017-2032) by Technology
        8.2.1    Market Overview
        8.2.2    IVF with ICSI
        8.2.3    IVF without ICSI
        8.2.4    Intrauterine Insemination
        8.2.5    Others
    8.3    Europe Surrogacy Market (2017-2032) by Country
        8.3.1    United Kingdom
        8.3.2    Germany
        8.3.3    France
        8.3.4    Italy
        8.3.5    Others
9    Asia Pacific Surrogacy Market (2017-2032)
    9.1    Asia Pacific Surrogacy Market (2017-2032) by Type
        9.1.1    Market Overview
        9.1.2    Gestational Surrogacy
        9.1.3    Traditional Surrogacy
    9.2    Asia Pacific Surrogacy Market (2017-2032) by Technology
        9.2.1    Market Overview
        9.2.2    IVF with ICSI
        9.2.3    IVF without ICSI
        9.2.4    Intrauterine Insemination
        9.2.5    Others
    9.3    Asia Pacific Surrogacy Market (2017-2032) by Country
        9.3.1    China
        9.3.2    Japan
        9.3.3    India
        9.3.4    Australia
        9.3.5    ASEAN
        9.3.6    Others
10    Latin America Surrogacy Market (2017-2032)
    10.1    Latin America Surrogacy Market (2017-2032) by Type
        10.1.1    Market Overview 
        10.1.2    Gestational Surrogacy
        10.1.3    Traditional Surrogacy
    10.2    Latin America Surrogacy Market (2017-2032) by Technology
        10.2.1    Market Overview
        10.2.2    Gestational Surrogacy
        10.2.3    Traditional Surrogacy
    10.3    Latin America Surrogacy Market (2017-2032) by Country
        10.3.1    Brazil
        10.3.2    Argentina
        10.3.3    Mexico
        10.3.4    Others
11    Middle East and Africa Surrogacy Market (2017-2032)
    11.1    Middle East and Africa Surrogacy Market (2017-2032) by Type
        11.1.1    Market Overview
        11.1.2    Gestational Surrogacy
        11.1.3    Traditional Surrogacy
    11.2    Middle East and Africa Surrogacy Market (2017-2032) by Technology
        11.2.1    Market Overview
        11.2.2    IVF with ICSI
        11.2.3    IVF without ICSI
        11.2.4    Intrauterine Insemination
        11.2.5    Others
    11.3    Middle East and Africa Surrogacy Market (2017-2032) by Country
        11.3.1    Saudi Arabia
        11.3.2    United Arab Emirates
        11.3.3    Nigeria
        11.3.4    South Africa
        11.3.5    Others
12    Patent Analysis
    12.1    Analysis by Type of Patent
    12.2    Analysis by Publication year
    12.3    Analysis by Issuing Authority
    12.4    Analysis by Patent Age
    12.5    Analysis by CPC Analysis
    12.6    Analysis by Patent Valuation 
    12.7    Analysis by Key Players
13    Grants Analysis
    13.1    Analysis by year
    13.2    Analysis by Amount Awarded
    13.3    Analysis by Issuing Authority
    13.4    Analysis by Grant Application
    13.5    Analysis by Funding Institute
    13.6    Analysis by NIH Departments
    13.7    Analysis by Recipient Organization 
14    Funding and Investment Analysis
    14.1    Analysis by Funding Instances
    14.2    Analysis by Type of Funding
    14.3    Analysis by Funding Amount
    14.4    Analysis by Leading Players
    14.5    Analysis by Leading Investors
    14.6    Analysis by Geography
15    Partnership and Collaborations Analysis
    15.1    Analysis by Partnership Instances
    15.2    Analysis by Type of Partnership
    15.3    Analysis by Leading Players
    15.4    Analysis by Geography
16    Regulatory Framework
    16.1    Regulatory Overview
        16.1.1    US FDA
        16.1.2    EU EMA
        16.1.3    INDIA CDSCO
        16.1.4    JAPAN PMDA
        16.1.5    Others
17    Supplier Landscape
    17.1    New Hope Fertility Clinic
        17.1.1    Financial Analysis
        17.1.2    Product Portfolio
        17.1.3    Demographic Reach and Achievements
        17.1.4    Mergers and Acquisitions
        17.1.5    Certifications
    17.2    Houston Fertility Center
        17.2.1    Financial Analysis
        17.2.2    Product Portfolio
        17.2.3    Demographic Reach and Achievements
        17.2.4    Mergers and Acquisitions
        17.2.5    Certifications
    17.3    Ovation Fertility
        17.3.1    Financial Analysis
        17.3.2    Product Portfolio
        17.3.3    Demographic Reach and Achievements
        17.3.4    Mergers and Acquisitions
        17.3.5    Certifications
    17.4    Extraordinary Conceptions
        17.4.1    Financial Analysis
        17.4.2    Financial Portfolio
        17.4.3    Demographic Reach and Achievements
        17.4.4    Mergers and Acquisitions
        17.4.5    Certifications
    17.5    CARE Fertility
        17.5.1    Financial Analysis
        17.5.2    Product Portfolio
        17.5.3    Demographic Reach and Achievements
        17.5.4    Mergers and Acquisitions
        17.5.5    Certifications
    17.6    Growing Generations, LLC
        17.6.1    Financial Analysis
        17.6.2    Product Portfolio
        17.6.3    Demographic Reach and Achievements
        17.6.4    Mergers and Acquisitions
        17.6.5    Certifications
    17.7    IVI RMA GLOBAL
        17.7.1    Financial Analysis
        17.7.2    Product Portfolio
        17.7.3    Demographic Reach and Achievements
        17.7.4    Mergers and Acquisitions
        17.7.5    Certifications
    17.8    CLINIC SCANFERT
        17.8.1    Financial Analysis
        17.8.2    Product Portfolio
        17.8.3    Demographic Reach and Achievements
        17.8.4    Mergers and Acquisitions
        17.8.5    Certifications
    17.9    BOURN HALL FERTILITY CLINIC
        17.9.1    Financial Analysis
        17.9.2    Product Portfolio
        17.9.3    Demographic Reach and Achievements
        17.9.4    Mergers and Acquisitions
        17.9.5    Certifications
    17.10    NOVA IVI FERTILITY
        17.10.1    Financial Analysis
        17.10.2    Product Portfolio
        17.10.3    Demographic Reach and Achievements
        17.10.4    Mergers and Acquisitions
        17.10.5    Certifications
    17.11    Associates Reproductive Medicine & Infertility
        17.11.1    Financial Analysis
        17.11.2    Product Portfolio
        17.11.3    Demographic Reach and Achievements
        17.11.4    Mergers and Acquisitions
        17.11.5    Certifications
    17.12    Cardone
        17.12.1    Financial Analysis
        17.12.2    Product Portfolio
        17.12.3    Demographic Reach and Achievements
        17.12.4    Mergers and Acquisitions
        17.12.5    Certifications
18    Global Surrogacy Market (2017-2032) Distribution Model (Additional Insight)
    18.1    Overview 
    18.2    Potential Distributors 
    18.3    Key Parameters for Distribution Partner Assessment 
19    Key Opinion Leaders (KOL) Insights (Additional Insight)
20    Company Competitiveness Analysis (Additional Insight)
    20.1    Very Small Companies
    20.2    Small Companies
    20.3    Mid-Sized Companies
    20.4    Large Companies
    20.5    Very Large Companies
21    Payment Methods (Additional Insight)
    21.1    Government Funded
    21.2    Private Insurance
    21.3    Out-of-Pocket

*Additional insights provided are customisable as per client requirements.

* The coverage of the Market Landscape section depends on the data availability and may cover a minimum of 80% of the total market. The EMR team strives to make this section as comprehensive as possible.